Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Rupert Bauersachs"'
Autor:
Cecilia Becattini, Giancarlo Agnelli, Melina Verso, Rupert Bauersachs, Menno V. Huisman, Andrés Muñoz, Mario Mandalà, Giorgio Vescovo
Publikováno v:
European Journal of Cancer, 148, 371-381. ELSEVIER SCI LTD
Background: Whether concomitant administration of anticancer agents influences the efficacy and safety of oral anticoagulants in patients treated for cancer-associated venous thromboembolism (VTE) is undefined. The pharmacological interaction between
Autor:
Rupert Bauersachs, Walter Ageno, Gualberto Gussoni, Ander Cohen, Cecilia Becattini, Giancarlo Agnelli, Maria Cristina Vedovati, Menno V. Huisman
Publikováno v:
Thrombosis and Haemostasis
Thrombosis and Haemostasis. GEORG THIEME VERLAG KG
Thrombosis and Haemostasis. GEORG THIEME VERLAG KG
Background Direct oral anticoagulants are recommended for the treatment of cancer-associated thrombosis (CAT) as an alternative to low-molecular-weight heparin (LMWH), but an increased bleeding risk in patients with gastrointestinal cancer was report
Autor:
Antonio Sanchez, Cecilia Becattini, Giancarlo Agnelli, Dario Manfellotto, Alexander T. Cohen, Laurent Bertoletti, Jean M. Connors, Benjamin Brenner, Rupert Bauersachs, Giorgio Maraziti
The effect of renal impairment (RI) on risk of bleeding and recurrent thrombosis in cancer patients treated with direct oral anticoagulants for venous thromboembolism (VTE) is undefined. We ran a prespecified analysis of the randomized Caravaggio stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b4c133a6e7734f10f05cbbf5933b7cd
https://hdl.handle.net/11391/1508707
https://hdl.handle.net/11391/1508707
Autor:
Cecilia Becattini, Benjamin Brenner, Giancarlo Agnelli, Maria Rosales Suero, Andrés Muñoz, Adam Torbicki, Gualberto Gussoni, Isabelle Mahé, Laura Franco, Rupert Bauersachs, Jean M. Connors, Eva N. Hamulyak, Catherine Lambert
Publikováno v:
Thrombosis and haemostasis, Vol. 122, no.5, p. 796-807 (2022)
Thrombosis and haemostasis. Schattauer GmbH
Thrombosis and haemostasis. Schattauer GmbH
Efficacy and safety of anticoagulant treatment for venous thromboembolism (VTE) may vary in patients with different cancer sites. We evaluated the rates of VTE recurrence and major bleeding and the relative efficacy and safety of 6-month treatment wi
Autor:
Kelley R. Branch, Manesh R. Patel, Sonia S. Anand, Eva Muehlhofer, Leanne Dyal, Will Hiatt, Marc P. Bonaca, Rupert Bauersachs, Keith A.A. Fox, Sebastian Debus, Michael Szarek, Lloyd Haskell, Scott D. Berkowitz, Salim Yusuf, John W. Eikelboom, Mark R. Nehler, Yan Liang
Publikováno v:
European journal of preventive cardiology. 29(5)
Aims Peripheral artery disease (PAD) patients suffer a high risk of major cardiovascular (CV) events, with athero-thrombo-embolism as the underlying pathophysiologic mechanism. Recently, two large randomized clinical trials evaluated the efficacy and
Autor:
Victor Aboyans, Francesco Violi, Jean-Baptiste Ricco, Manesh R. Patel, Jackie Bosch, Eike Sebastian Debus, Peter Verhamme, Jean-François Tanguay, Rupert Bauersachs, Daniele Pastori, Lucia Mazzolai, Sonia S. Anand, John W. Eikelboom, Mark R. Nehler, Sigrid Nikol
Publikováno v:
Thrombosis and Haemostasis
Thrombosis and Haemostasis, Schattauer, 2019
Thrombosis and Haemostasis, Schattauer, 2019
The most common causes of ischaemic stroke are represented by carotid artery atherosclerotic disease (CAAD) and atrial fibrillation. While oral anticoagulants substantially reduce the incidence of thromboembolic stroke (< 1%/year), the rate of ischae
Direct oral anticoagulants for the treatment of pulmonary embolism in patients with renal impairment
Publikováno v:
Thrombosis research. 204
Pulmonary embolism (PE) is associated with adverse outcomes and substantial morbidity and mortality. Patients with PE often have renal impairment because of shared risk factors and close links between the renal and cardiovascular systems. Furthermore
Autor:
Menno V. Huisman, Giancarlo Agnelli, Cecilia Becattini, Alexander T. Cohen, Francesco Dentali, Jean M. Connors, Ana Belen Ruperez Blanco, Nicolas Falvo, Michela Giustozzi, Sebastian Szmit, Rupert Bauersachs
Publikováno v:
Journal of Thrombosis and Haemostasis, 19(11), 2751-2759. WILEY
Background Clinical guidelines advise similar anticoagulant treatment for symptomatic and incidental cancer-associated venous thromboembolism (VTE). We investigated clinical features and outcomes of cancer patients with incidental or symptomatic VTE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::235c324b59acb20d5f9828356d9b8f67
http://hdl.handle.net/11383/2123920
http://hdl.handle.net/11383/2123920
Publikováno v:
European Journal of Vascular and Endovascular Surgery. 62:142-143
Autor:
Ulrich Hoffmann, Rupert Bauersachs, Thomas Noppeney, Jens Klotsche, Horst E. Gerlach, Andreas Heinken, Eberhard Rabe, Florian Länger, David Pittrow
Publikováno v:
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery. 62(2)
Objective Management and outcomes of superficial vein thrombosis (SVT) are highly variable and not well described. Therefore, the INvestigating SIGnificant Health TrendS in the management of SVT (INSIGHTS-SVT) study collected prospective data under r